Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo

Laura E. Wright, Ahmed A. Harhash, Wende M. Kozlow, David L. Waning, Jenna N. Regan, Yun She, Sutha K. John, Sreemala Murthy, Maryla Niewolna, Andrew R. Marks, Khalid S. Mohammad, Theresa A. Guise

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences